Literature for peptidase S07.001: flavivirin

(References are filtered for relevance to Review. To remove the filter click here. See explanation.)

2024
1. Akram,M., Hameed,S., Hassan,A. and Khan,K.
   Development in the Inhibition of Dengue Proteases as Drug Targets
   Curr Med Chem31, 2195-2233. PubMed  Europe PubMed DOI  V
2. Cavina,L., Bouma,M.J., Girones,D. and Feiters,M.C.
   Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition
   Molecules29, PubMed  Europe PubMed DOI  V  I
3. Mushtaq,M., Siddiqui,A.R., Shafeeq,S., Khalid,A. and Ul-Haq,Z.
   Shifting paradigms: The promise of allosteric inhibitors against dengue virus protease
   Int J Biol Macromol282, 137056-137056. PubMed  Europe PubMed DOI  V
2023
4. Incicco,J.J., Cababie,L.A., Sarto,C., Adler,N.S., Amrein,F., Mikkelsen,E., Arrar,M. and Kaufman,S.B.
   Thermodynamic and mechanistic analysis of the functional properties of dengue virus NS3 helicase
   Biophys Rev15, 591-600. PubMed  Europe PubMed DOI  V
2022
5. Samrat,S.K., Xu,J., Li,Z., Zhou,J. and Li,H.
   Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
   Pathogens11, PubMed  Europe PubMed DOI  V
2021
6. Murtuja,S., Shilkar,D., Sarkar,B., Sinha,B.N. and Jayaprakash,V.
   A short survey of dengue protease inhibitor development in the past 6 years (2015-2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases
   Bioorg Med Chem49, 116415-116415. PubMed  Europe PubMed DOI  V
2014
7. Nitsche,C., Holloway,S., Schirmeister,T. and Klein,C.D.
   Biochemistry and medicinal chemistry of the dengue virus protease
   Chem Rev114, 11348-11381. PubMed  Europe PubMed DOI  V
2010
8. Steuber,H. and Hilgenfeld,R.
   Recent advances in targeting viral proteases for the discovery of novel antivirals
   Curr Top Med Chem10, 323-345. PubMed  Europe PubMed DOI  V
2004
9. Kummerer,B.M., Amberg,S.M. and Rice,C.M.
   Flavivirin
   [ISSN:0-12-079610-4]2, 1769-1773.  V